News and perspectives
Press releases
UNOS Responds to Recent HRSA Statements
HRSA comments about UNOS were inaccurate.
Open letter from Maureen as she leaves UNOS
Former UNOS CEO reflects on her decades of service.
UNOS reaches contract agreement with HRSA
UNOS has reached an agreement with HRSA on a contract for OPTN work that will take effect on Dec. 30, 2025, immediately following the expiration of our current contract.
UNOS CEO Maureen McBride announces retirement
After 30 years with UNOS, Dr. Maureen McBride is retiring; “Working at UNOS has been the privilege of my lifetime.”
UNOS and Leading Organ Donation and Transplant Organizations Urge Congress to Maintain Key Priorities in Final FY26 Federal Government Funding Legislation
Coalition of 15 organizations thanks the U.S. Senate and U.S. House Labor-HHS Appropriations Subcommittees leaders for including policies that improve organ donation and transplant.
UNOS responds to Ways & Means hearing
UNOS statement following Dec. 2 Ways & Means hearing
UNOS responds to Congressional hearing
UNOS statement following July 22 congressional hearing.
UNOS CEO Maureen McBride responds to July 20 New York Times article
UNOS CEO Maureen McBride responds to new article by New York Times.
Learn about issues impacting patients, donors, donor families, and the national system.
About UNOS
Issues and advocacy
Strengthening organ donation and transplant
- Collaborating to support donation and transplant internationally.
- The waitlist is better described as a giant pool of patients. Watch a video
Working together: Our nation’s organ donation and transplant system
- The OPTN, HRSA and CMS have different roles. Learn about the roles
UNOS is a nonprofit on a mission to save and transform lives through research, innovation and collaboration. UNOS builds on its experience and expertise to strengthen organ donation and transplantation systems and enhance public health. The nonprofit helps people live life without limits by developing products and services, conducting data-driven research and analysis, providing expert consulting services, advocating for reforms to help patients, and partnering to drive a greater impact.